Allergan fourth-quarter launch lifts year
This article was originally published in Clinica
Executive Summary
Allergan's medical device business grew in line with the company as a whole, with adverse currency effects still diminishing the figures slightly. However, the underlying trend, adjusted for currency translation losses, is marginally upward.